Condition: Corneal Transplant Failure · Sponsor: Massachusetts Eye and Ear Infirmary
The main objective of this study is to determine the safety of Ex Vivo Cross Linking (CXL) of donor corneal tissue in participants who have undergone high-risk penetrating keratoplasty.
This description comes directly from the study's public registry record.
Michael Cheung, MSc, CCRP · 6175736060 · mcheung0@meei.harvard.edu
Nikolay Boychev, OD, PhD
Always discuss trial participation with your own doctor first.
| University of California Irvine - Gavin Herbert Eye Institute | Irvine, California, United States | Not Yet Recruiting |
| The University of California Los Angeles - Doris Stein Eye Research Center | Los Angeles, California, United States | Not Yet Recruiting |
| University of California San Francisco - Wayne and Gladys Valley Center for Vision | San Francisco, California, United States | Not Yet Recruiting |
| University of Miami - Bascom Palmer Eye Institute | Miami, Florida, United States | Recruiting |
| Price Vision Group | Indianapolis, Indiana, United States | Recruiting |
| Kansas City Eye Clinic | Overland Park, Kansas, United States | Recruiting |
| Mid-Atlantic Cornea Consultant | Towson, Maryland, United States | Not Yet Recruiting |
| Massachusetts Eye and Ear | Boston, Massachusetts, United States | Recruiting |
| University of Michigan - Kellogg Eye Center | Ann Arbor, Michigan, United States | Recruiting |
| Wake Forest Baptist Eye Center | Bermuda Run, North Carolina, United States | Not Yet Recruiting |
| Duke University - Duke Eye Center | Durham, North Carolina, United States | Recruiting |
| Cincinnati Eye Institute | Cincinnati, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06753916